HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Reduction of Nd:YAG capsulotomy rates after implantation of a single-piece acrylic hydrophilic intraocular lens with 360° squared optic edge: 24-month results.

AbstractBACKGROUND AND OBJECTIVE:
Posterior capsule opacification remains a significant problem following cataract surgery. The aim of the study was to evaluate the incidence of symptomatic posterior capsule opacification requiring Nd:YAG capsulotomy in patients who underwent cataract extraction and implantation of the Rayner C-flex 570C intraocular lens (IOL) (Rayner Intraocular Lens, Ltd., Sussex, UK).
PATIENTS AND METHODS:
A retrospective study of 3,461 eyes that underwent cataract extraction and insertion of the Rayner C-flex IOL from January 2004 to December 2005. The cases that received Nd: YAG capsulotomies were evaluated.
RESULTS:
Over a 24-month period, 3,461 Rayner C-flex IOLs were implanted. Nd:YAG capsulotomy was performed in 58 of these cases. The rate of Nd:YAG capsulotomy was 0.6% at 12 months and 1.7% at 24 months. The mean time to Nd:YAG capsulotomy was 9.3 months (range: 1.3 to 22.7 months). The follow-up period was 5.3 to 29.0 months.
CONCLUSION:
The incidence of symptomatic posterior capsule opacification with the Rayner C-flex IOL is low.
AuthorsRashmi G Mathew, Andrew G A Coombes
JournalOphthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye (Ophthalmic Surg Lasers Imaging) 2010 Nov-Dec Vol. 41 Issue 6 Pg. 651-5 ISSN: 1938-2375 [Electronic] United States
PMID20954645 (Publication Type: Journal Article)
CopyrightCopyright 2010, SLACK Incorporated.
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Capsule Opacification (epidemiology, etiology, surgery)
  • Cataract Extraction (adverse effects)
  • Equipment Design
  • Female
  • Follow-Up Studies
  • Humans
  • In Vitro Techniques
  • Incidence
  • Laser Therapy
  • Lasers, Solid-State (therapeutic use)
  • Lens Implantation, Intraocular (adverse effects, statistics & numerical data)
  • Lenses, Intraocular
  • Middle Aged
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: